Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telotristat etiprate in symptomatic carcinoid syndrome
NCT00853047Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Mar 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telotristat ethyl in Carcinoid Syndrome (CS), sponsored by Lexicon Pharmaceuticals, Inc.. Started Mar 2009; status: completed.
02
Drugs
telotristat ethyl
03
Conditions
Carcinoid Syndrome (CS)
Beyond the preview
Go deeper on NCT00853047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853047.